Last reviewed · How we verify
NCT05845970
An Investigation Into the Efficacy of a Botanical Supplement to Provide Period Relief
Phase 1 trial testing Pamprin Botanicals in Menstrual Pain in 100 participants. Completed in 1 July 2023.
1 June 2023
Quick facts
| Lead sponsor | Focus Consumer Healthcare |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 8 February 2023 |
| Primary completion | 1 June 2023 |
| Estimated completion | 1 July 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Pamprin Botanicals
- Pamprin Botanicals + Pamprin Menstrual Pain Relief
Conditions studied
- Menstrual Pain — all drugs for Menstrual Pain →
- Premenstrual Syndrome — all drugs for Premenstrual Syndrome →
Sponsor
Focus Consumer Healthcare
Who can join
Adults 18 to 40, female only, with Menstrual Pain or Premenstrual Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Women often experience significant pain during their periods which can significantly impact on quality of life. In this study, two products that are used to alleviate period pain will be examined. One test product is botanically based, and the other is a traditional over-the-counter pain reliever with additional components added to support less painful periods. The trial will be a cross-over trial where participants will use the botanical product before, during, and after their first period. Participants will use the botanical product alongside a traditional over-the-counter period product during their second period. Participants will answer surveys and have blood drawn at a third-party lab to answer the main objectives of this trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05845970
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Menstrual Pain
Currently open trials in the same condition.
- NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
- NCT07209566 — A Research Study Exploring How Musculoskeletal Function and the Autonomic Nervous System Relate to Visceral Pain in Wome · NA · recruiting
- NCT06921629 — Menstrual Complaints in Adolescents and Adults · active not recruiting
Other Focus Consumer Healthcare trials
Trials by the same sponsor.
- NCT05796635 — An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05845970 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Focus Consumer Healthcare
- Last refreshed: 29 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05845970.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing